Gastric Cancer
Hokkaido University, Department of Gastroenterology publishes research in gastric cancer
Published in Cancer Weekly, August 10th, 2010
Fresh data on gastric cancer are presented in the report 'Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer.' According to recent research from Sapporo, Japan, "Irinotecan and S-1, an oral fluoropyrimidine composed of tegafur, gimeracil, and oteracil potassium, have demonstrated antitumor activity against advanced gastric cancer. We performed a phase 1/2 study to determine the recommended dose, antitumor activity, and safety of a combination of S-1 and irinotecan in patients with advanced gastric cancer."
"Patients with previously untreated advanced gastric cancer were enrolled. Patients received irinotecan intravenously...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-08-10)
More Articles from Cancer Weekly
- Breast Cancer
American Greetings Introduces Greeting Cards in Support of the National Breast Cancer Foundation - Ovarian Cancer
Arrayit Corporation Taps Former IVAX Diagnostics Executive to Build Strategic Partnerships - Colorectal Research
CTC screening for colorectal cancer not cost-effective when reimbursed at same rate as colonoscopy - Ovarian Cancer
Carolyn Pollack Designs and Donates Turquoise Necklace for QVC's Super SaturdaySM Charity Event - Bladder Cancer
Data on bladder cancer published by E. Solsona and colleagues - Colon Cancer
Data on colon cancer discussed by researchers at University of Rochester, Department of Radiation Oncology - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
